Exencial Wealth Advisors, LLC Novo Nordisk A S Transaction History

Exencial Wealth Advisors, LLC

$2.63 Billion
Q1 2025

A detailed history of Exencial Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 23,601 shares of NVO stock, worth $1.66 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

23,601

Previous 23,094 2.2%

Holding current value

$1.66 Million

Previous $1.99 Million 17.52%

% of portfolio

0.06%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$69.3 - $90.95 $35,135 - $46,111	507 Added 2.2%	23,601 $1.64 Million
Q4 2024 Feb 06, 2025	BUY	$85.0 - $120.04 $10,540 - $14,884	124 Added 0.54%	23,094 $1.99 Million
Q3 2024 Oct 31, 2024	BUY	$119.07 - $145.42 $70,727 - $86,379	594 Added 2.65%	22,970 $2.74 Million
Q2 2024 Aug 12, 2024	SELL	$122.71 - $146.91 $28,836 - $34,523	-235 Reduced 1.04%	22,376 $3.19 Million
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $143,770 - $191,375	1,408 Added 6.64%	22,611 $2.9 Million
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $129,826 - $155,960	-1,479 Reduced 6.52%	21,203 $2.19 Million
Q3 2023 Nov 08, 2023	BUY	$90.94 - $199.54 $933,862 - $2.05 Million	10,269 Added 82.73%	22,682 $2.06 Million
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $83,605 - $92,540	536 Added 4.51%	12,413 $2.01 Million
Q1 2023 May 02, 2023	SELL	$132.34 - $159.14 $9.54 Million - $11.5 Million	-72,108 Reduced 85.86%	11,877 $1.89 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $1.39 Million - $1.83 Million	-13,533 Reduced 13.88%	83,985 $11.4 Million
Q3 2022 Nov 08, 2022	BUY	$95.28 - $116.93 $287,650 - $353,011	3,019 Added 3.19%	97,518 $9.72 Million
Q2 2022 Aug 11, 2022	SELL	$103.24 - $121.81 $3.52 Million - $4.15 Million	-34,074 Reduced 26.5%	94,499 $10.5 Million
Q1 2022 May 12, 2022	BUY	$93.1 - $112.54 $658,403 - $795,882	7,072 Added 5.82%	128,573 $14.3 Million
Q4 2021 Feb 10, 2022	BUY	$95.88 - $117.08 $675,954 - $825,414	7,050 Added 6.16%	121,501 $13.6 Million
Q3 2021 Nov 04, 2021	BUY	$84.42 - $106.62 $235,700 - $297,683	2,792 Added 2.5%	114,451 $11 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $225,037 - $281,911	3,326 Added 3.07%	111,659 $9.35 Million
Q1 2021 May 06, 2021	BUY	$67.06 - $75.82 $715,194 - $808,620	10,665 Added 10.92%	108,333 $7.3 Million
Q4 2020 Feb 11, 2021	SELL	$63.89 - $73.8 $5.66 Million - $6.54 Million	-88,592 Reduced 47.56%	97,668 $6.82 Million
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $6.54 Million - $7.21 Million	102,692 Added 122.88%	186,260 $12.9 Million
Q2 2020 Aug 17, 2020	BUY	$58.54 - $67.94 $4.89 Million - $5.68 Million	83,568 New	83,568 $5.47 Million

Others Institutions Holding NVO

# of Institutions

1,768

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $159B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.

Account

Exencial Wealth Advisors, LLC Novo Nordisk A S Transaction History